Acute myeloid leukemia: current progress and future directions

Progress in the understanding of the biology and therapy of acute myeloid leukemia (AML) is occurring rapidly. Since 2017, nine agents have been approved for various indications in AML. These included several targeted therapies like venetoclax, FLT3 inhibitors, IDH inhibitors, and others. The manage...

Descripción completa

Detalles Bibliográficos
Autores principales: Kantarjian, Hagop, Kadia, Tapan, DiNardo, Courtney, Daver, Naval, Borthakur, Gautam, Jabbour, Elias, Garcia-Manero, Guillermo, Konopleva, Marina, Ravandi, Farhad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7900255/
https://www.ncbi.nlm.nih.gov/pubmed/33619261
http://dx.doi.org/10.1038/s41408-021-00425-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7900255/
https://www.ncbi.nlm.nih.gov/pubmed/33619261
http://dx.doi.org/10.1038/s41408-021-00425-3

Ejemplares similares